Perrigo rejects new Mylan bid

Investor's Business Daily
April 2015
Investors Business Daily;4/30/2015, pA02
The article reports that drugstore supplier Perrigo Co. PLC has rejected the bid offered by American generic-drug maker Mylan NV following speculations that the bid would be bought by pharmaceutical company Teva Pharmaceutical Industries Ltd.


Related Articles

  • Mylan. Investor's Business Daily // Investors Business Daily;7/30/2015, pA02 

    The article reports on the announcement of pharmaceutical firm Mylan NV that it has received approval from regulations in Europe to push through with its proposal to aquire healthcare supplier Perrigo Co. PLC.

  • Drugmaker Drama Ends Without Hitch: Perrigo Shareholders Rebuff Mylan Bid. AMY REEVES // Investors Business Daily;11/13/2015, p00 

    The article reports that Perrigo Co. PLC's shareholders have opposed a hostile takeover bid by generic-drug manufacturer Mylan NV, resulting to the decline of Perrigo stock and an increase in Mylan stock. It reveals that Mylan stock posted a 12.9% increase while Perrigo stock has dropped by 6.2%...

  • Hostile And Hopeful Teva Offers $40 Bil For Mylan. AMY REEVES // Investors Business Daily;4/22/2015, pA01 

    The article focuses on the $40 billion bid of Israeli pharmaceutical company Teva Pharmaceutical Industries Ltd. to acquire its competitor Mylan NV, which also shows interest to buy generic drug maker Perrigo Co. LLC. The stand of Mylan on Teva's acquisition bid is discussed. Also explained is...

  • Abbott Affirms its Support for Mylan's proposed acquisition of Perrigo.  // eHEALTH;6/18/2015, p1 

    The article reports that global healthcare company Abbott has confirmed that it will continue support for pharmaceutical firm Mylan NV's growth strategy by stating its intent to support Mylan's proposed acquisition of pharmaceutical firm Perrigo. Topics include Abbott's intent to vote its 14.5...

  • Mylan 'Raises' Perrigo Bid, But Teva Buzz Builds. ED CARSON // Investors Business Daily;4/24/2015, p00 

    The article focuses on the decision of generic drugmaker Mylan to increase its offer for pharmaceutical company Perrigo. It states that Perrigo promptly rejected Mylan's bid, saying the takeover proposal was worse than before. In addition, Perrigo rejected Mylan's bid since its stocks has been...

  • OPINION.  // Crain's Detroit Business;11/16/2015, Vol. 31 Issue 46, p0008 

    In the article, the author discusses economic and business developments in Michigan as of mid-November 2015. Based on the Business Leaders of Michigan benchmarking report, Michigan is number 46 in terms of annual unemployment in the U.S., number 36 in per capita income, and 34th in per capita...

  • Mylan Rejects 'Low Quality'. Investor's Business Daily // Investors Business Daily;4/28/2015, pA01 

    9 In rejecting a takeover bid from

  • Mylan Offers Perrigo $29 Bil. Investor's Business Daily // Investors Business Daily;4/9/2015, pA01 

    2 Unsolicited, the generic drugmaker bid $205 a share to buy

  • India has a lot to offer both in innovation and operation.  // Business Today;10/25/2015, Vol. 24 Issue 21, p42 

    The article presents an interview with Heather Bresch, CEO of pharmaceuticals company, Mylan. She talks about the efforts to acquire Ireland-based rival Perrigo, the acquisition of Europe based Merck KgaA and India based Matrix Laboratories, Agila and Famycare and investments made in Research...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics